CHIORAZZI, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 12.032
EU - Europa 6.880
AS - Asia 4.407
SA - Sud America 232
OC - Oceania 42
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 23
Totale 23.643
Nazione #
US - Stati Uniti d'America 11.814
SG - Singapore 1.916
IT - Italia 1.568
DE - Germania 1.313
CN - Cina 1.244
SE - Svezia 942
IE - Irlanda 822
RU - Federazione Russa 654
UA - Ucraina 534
HK - Hong Kong 512
GB - Regno Unito 323
CA - Canada 200
VN - Vietnam 197
BR - Brasile 195
AT - Austria 169
FI - Finlandia 147
ID - Indonesia 138
DK - Danimarca 115
FR - Francia 109
IN - India 95
JP - Giappone 74
TR - Turchia 61
NL - Olanda 54
BE - Belgio 45
KR - Corea 36
IR - Iran 30
AU - Australia 24
EU - Europa 23
MY - Malesia 20
NZ - Nuova Zelanda 18
ES - Italia 15
PL - Polonia 13
TW - Taiwan 12
AR - Argentina 10
MX - Messico 10
EG - Egitto 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
HU - Ungheria 8
PK - Pakistan 8
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
BD - Bangladesh 6
EC - Ecuador 6
HR - Croazia 6
BG - Bulgaria 5
IL - Israele 5
IQ - Iraq 5
UZ - Uzbekistan 5
AL - Albania 4
CO - Colombia 4
JO - Giordania 4
KG - Kirghizistan 4
LV - Lettonia 4
PY - Paraguay 4
RO - Romania 4
VE - Venezuela 4
ZA - Sudafrica 4
BO - Bolivia 3
CL - Cile 3
DO - Repubblica Dominicana 3
KZ - Kazakistan 3
MA - Marocco 3
PH - Filippine 3
PT - Portogallo 3
RS - Serbia 3
AO - Angola 2
BH - Bahrain 2
DZ - Algeria 2
GT - Guatemala 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MD - Moldavia 2
NG - Nigeria 2
OM - Oman 2
PE - Perù 2
SC - Seychelles 2
AM - Armenia 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
EE - Estonia 1
GE - Georgia 1
JM - Giamaica 1
KW - Kuwait 1
NO - Norvegia 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 23.643
Città #
Ann Arbor 2.859
Singapore 1.256
Dublin 797
Woodbridge 773
Chandler 772
Frankfurt am Main 744
Wilmington 634
Milan 589
Houston 580
Fairfield 565
Dearborn 547
Jacksonville 539
Ashburn 480
Hong Kong 475
New York 374
Santa Clara 336
Princeton 302
Nanjing 232
Seattle 231
Boardman 179
Cambridge 162
Vienna 155
Shanghai 150
Jakarta 128
Beijing 102
Dong Ket 92
Guangzhou 86
Lachine 85
Lawrence 78
Altamura 73
Council Bluffs 72
Nanchang 72
Shenyang 72
Andover 51
Carate Brianza 49
Chicago 48
Los Angeles 48
Rome 46
Helsinki 44
Falls Church 43
Toronto 43
Hangzhou 41
Pune 40
Fremont 39
Jinan 39
Nuremberg 39
Ottawa 39
San Diego 38
Brussels 36
Jiaxing 35
Kunming 34
Tianjin 30
Zhengzhou 30
Changsha 29
Hebei 29
Melzo 27
Nürnberg 27
Grafing 26
Norwalk 26
Sacramento 24
London 23
Bergamo 22
Florence 22
Shangdi 22
Tokyo 21
Mountain View 20
Ningbo 20
Dallas 19
Edmonton 18
Phoenix 17
São Paulo 17
Taizhou 17
Leawood 16
Codroipo 15
Hefei 15
Lissone 15
Philadelphia 15
Washington 15
Mainz 13
Paris 13
Cagliari 12
Catania 12
Lappeenranta 12
Pasir Mas 12
Shinjuku 12
Bologna 11
Canazei 11
Kiev 11
Rio de Janeiro 11
Wuhan 11
Daejeon 10
Norristown 10
Romola 10
Sesto San Giovanni 10
Changchun 9
Como 9
Fuzhou 9
Rende 9
Tehran 9
Huizen 8
Totale 16.154
Nome #
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 323
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 309
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 309
Age-related changes in the function and structure of the peripheral sensory pathway in mice 306
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 300
Studio della neurotossicità periferica indotta da farmaci antitubulinici in modelli sperimentali in vitro e in vivo 290
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 283
Artificial apolipoprotein corona enables nanoparticle brain targeting 272
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 261
Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders 255
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 249
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 247
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 234
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 226
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 224
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 222
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 214
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 211
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 208
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 205
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 204
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 203
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 201
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 198
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 193
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 192
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 191
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 189
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 189
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 189
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 186
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 185
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 183
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system 182
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 181
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 181
OCT2 transporter involvement in development of cisplatin toxicity 178
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 177
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 175
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 175
Facial emotion recognition in schizophrenia: An exploratory study on the role of comorbid alcohol and substance use disorders and COMT Val158Met 173
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 172
MSCs ameliorate clinical course in rats with experimental autoimmune encephalomyelitis 170
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 170
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: An in vitro study 169
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 169
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 168
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 167
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 167
Current view in platinum drug mechanisms of peripheral neurotoxicity 167
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 162
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 162
Lipoplatin tm: a less neurotoxic formulation of cisplatin 162
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 161
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 160
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 160
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 159
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 156
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 155
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 154
Granulocytes in actively induced Lewis rat EAE 153
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 150
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 148
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 146
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 145
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 144
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 144
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 144
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 143
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 143
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 143
Oxaliplatin induces pH acidification in dorsal root ganglia neurons 142
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 142
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 141
Epothilone B-induced toxic effects on peripheral nervous system: in vitro and in vivo experimental models 139
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 139
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 138
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 138
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 138
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 138
MSCs effect on Dark Agouti rats affected by chronic EAE 137
Multimodal experimental approach to the study of human neurological diseases 137
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 137
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 136
Genetic factors influencing the development of vincristine-induced neurotoxicity 136
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 135
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 135
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 135
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? 135
Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve 134
Evaluation of microtubule polimerization involved in the development of bortezomib-induced peripheral neuropathy through new in vitro and in vivo models 134
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 133
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 132
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 132
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 130
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 128
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 124
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 124
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 124
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 124
Totale 17.683
Categoria #
all - tutte 91.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.681


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020621 0 0 0 0 0 0 0 0 0 319 247 55
2020/20213.424 147 132 377 353 262 306 408 321 290 258 204 366
2021/20221.946 152 234 171 177 139 181 95 106 82 143 134 332
2022/20233.484 389 846 380 332 259 540 63 181 277 51 104 62
2023/20242.986 97 98 101 146 386 725 508 163 158 68 68 468
2024/20255.167 452 898 712 367 624 294 512 284 899 125 0 0
Totale 25.087